Private Trust Company’s Integra LifeSciences IART Stock Holding History

Private Trust Company’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-44	Closed	-$968	–	2519
2025 Q1	$968	Buy	+44	New	+$1.03K	﹤0.01%	2365
2023 Q4	–	Sell	-80	Closed	-$3.06K	–	2362
2023 Q3	$3.06K	Sell	80 -102	-56%	-$4.29K	﹤0.01%	2037
2023 Q2	$7.49K	Sell	182 -5	-3%	-$241	﹤0.01%	1743
2023 Q1	$10.7K	Hold	187	–	–	﹤0.01%	1556
2022 Q4	$10K	Sell	187 -24	-11%	-$1.22K	﹤0.01%	1549
2022 Q3	$9K	Hold	211	–	–	﹤0.01%	1489
2022 Q2	$11K	Buy	+211	New	+$12.7K	﹤0.01%	1453
2014 Q4	–	Sell	-32	Closed	-$1K	–	694
2014 Q3	$1K	Hold	32	–	–	﹤0.01%	1744
2014 Q2	$1K	Hold	32	–	–	﹤0.01%	1766
2014 Q1	$1K	Sell	32 -41	-56%	-$791	﹤0.01%	1633
2013 Q4	$1K	Hold	73	–	–	﹤0.01%	1634
2013 Q3	$1K	Hold	73	–	–	﹤0.01%	1580
2013 Q2	$1K	Buy	+73	New	+$1.07K	﹤0.01%	1525

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Private Trust Company's IART Position: Q2 2025 in Review

Private Trust Company sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 44 shares — an estimated $968 sold.

Private Trust Company first reported a position in IART in Q2 2013 and held it in 13 quarters. The position peaked at $11K in Q2 2022. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

Private Trust Company reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
Private Trust Company sold 44 Integra LifeSciences shares in Q2 2025, an estimated $968.
Private Trust Company first reported a position in Integra LifeSciences in Q2 2013 and held it in 13 quarters.
Private Trust Company's Integra LifeSciences position peaked at $11K in Q2 2022.
208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Private Trust Company's 13F filing for Q2 2025, filed 29 Jul 2025.